Brief: Initiator Pharma Q2 EBIT Was loss SEK 3,3 mln
Aug 24 (Reuters) - Initiator Pharma A/S INIT.TE :
* Q2 NET REVENUES WERE TDKK 0 (0)
* Q2 EBIT WAS TDKK -3,294 (-2,023)
Source text for Eikon: ID:nWkr1Y4bWb
Further company coverage: INIT.TE
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Initiator Pharma A/S
See all newsBrief: Initiator Pharma Q1 2026 Operating Loss DKK 11.4 Mln
Brief: Initiator Pharma To Fully Prioritize Pudafensine
Brief: Initiator Pharma Reports Q4 Net Revenue Of DKK 0.00
Brief: Initiator Pharma Q4 Operating Loss Widens To DKK 7 Mln
Brief: Initiator Pharma Granted European Patent For Pudafensine in FSD